Applied Clinical Trials-02-01-2012

February 01, 2012

TRIAL DESIGN : Enrollment is More Than a Numbers Game REGULATORY : Late Phase PK Collection Also in this issue : Protocol Design and Study Management, Effects of Europe?s Economic Turbulence, Ready for Big Data?, Outcomes Assessments

February 01, 2012

Medidata Solutions

February 01, 2012

Industry Standards Research

February 01, 2012

The best relationships between sponsors and contractors are those that are well defined from the outset.

February 01, 2012

PPD has begun training its Clinical Research Associates in a virtual classroom.

February 01, 2012

Industry news focusing on the people and organizations who work in the clinical trials profession.

February 01, 2012

Europe's struggling economies may have unexpected effects on the pharmaceutical sector.

February 01, 2012

All measurements and outcomes need to reflect what is happening with the patient.

February 01, 2012

FDA wants sponsors to build quality into protocols, adopt risk-based strategies to streamline trials.

February 01, 2012

Five key pieces to a lasting and successful sponsor/CRO relationship.

February 01, 2012

PAREXEL's Neal Mantick discusses the strategic advantage of the transition from clinical research to commercial.

February 01, 2012

Pzizer's Craig Lipset answers questions about the ongoing REMOTE trial.

February 01, 2012

Vendors have developed systems for massive databases, but are we data ready?

February 01, 2012

Partnering with CROs and using a blinded independent central review can increase trial success.

February 01, 2012

A British Medical Journal survey suggests that misconduct in research is not going away.

February 01, 2012

Collecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.